Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage

Mitsi, Elena, Roche, A M, Reiné, Jesús, Zangari, T, Owugha, Jessica, Pennington, Shaun ORCID: https://orcid.org/0000-0002-7160-6275, Gritzfeld, Jenna, Wright, Angela, Collins, Andrea ORCID: https://orcid.org/0000-0002-4094-1572, Van Selm, S, De Jong, M I, Gordon, Stephen ORCID: https://orcid.org/0000-0001-6576-1116, Weiser, J N and Ferreira, Daniela ORCID: https://orcid.org/0000-0002-0594-0902 (2016) 'Agglutination by anti-capsular polysaccharide antibody is associated with protection against experimental human pneumococcal carriage'. Mucosal Immunology, Vol 10, pp. 385-394.

Text 20160711- Agg. Mucosal Immunology-Revised version.docx Available under License Creative Commons Attribution. Download (122kB)

Abstract

The ability of pneumococcal conjugate vaccine (PCV) to decrease transmission by blocking the acquisition of colonization has been attributed to herd immunity. We describe the role of mucosal immunoglobulin G (IgG) to capsular polysaccharide (CPS) in mediating protection from carriage, translating our findings from a murine model to humans. We used a flow cytometric assay to quantify antibody-mediated agglutination demonstrating that hyperimmune sera generated against an unencapsulated mutant was poorly agglutinating. Passive immunization with this antiserum was ineffective to block acquisition of colonization compared to agglutinating antisera raised against the encapsulated parent strain. In the human challenge model, samples were collected from PCV and control-vaccinated adults. In PCV-vaccinated subjects, IgG levels to CPS were increased in serum and nasal wash (NW). IgG to the inoculated strain CPS dropped in NW samples after inoculation suggesting its sequestration by colonizing pneumococci. In post-vaccination NW samples pneumococci were heavily agglutinated compared with pre-vaccination samples in subjects protected against carriage. Our results indicate that pneumococcal agglutination mediated by CPS-specific antibodies is a key mechanism of protection against acquisition of carriage. Capsule may be the only vaccine target that can elicit strong agglutinating antibody responses, leading to protection against carriage acquisition and generation of herd immunity.

Item Type:	Article
Subjects:	QW Microbiology and Immunology > QW 4 General works. Classify here works on microbiology as a whole. QW Microbiology and Immunology > Immune Responses > QW 640 Agglutination. Precipitation WC Communicable Diseases > Infection. Bacterial Infections > Bacterial Infections > WC 217 Pneumococcal infections
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1038/mi.2016.71
Depositing User:	Stacy Murtagh
Date Deposited:	06 Oct 2016 11:32
Last Modified:	05 Nov 2019 14:57
URI:	https://archive.lstmed.ac.uk/id/eprint/6241

Statistics

View details

Actions (login required)

Edit Item